Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen

BACKGROUND: It remains controversial whether palliative primary tumor resection (PPTR) can provide survival benefits to the patients with metastatic colorectal cancer (mCRC) who have unresectable metastases. The aim of this study was to evaluate whether PPTR could improve the survival of patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wen-Zhuo, Rong, Yu-Ming, Jiang, Chang, Liao, Fang-Xin, Yin, Chen-Xi, Guo, Gui-Fang, Qiu, Hui-Juan, Zhang, Bei, Xia, Liang-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928252/
https://www.ncbi.nlm.nih.gov/pubmed/27357402
http://dx.doi.org/10.1186/s40880-016-0120-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928252/
https://www.ncbi.nlm.nih.gov/pubmed/27357402
http://dx.doi.org/10.1186/s40880-016-0120-4

Ejemplares similares